ACADIA PHARMACEUTICALS A/S: Financial statements 2018
CVR: 19670694
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ACADIA PHARMACEUTICALS A/S (CVR 19670694) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK -46,546 compared with DKK -73,652 the year before. Equity in the 2018 report amounted to DKK -435,027.
- Profit/Loss
- DKK -46,546
- Equity
- DKK -435,027
- Total Assets
- DKK 6,286
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | -47 t. | -435 t. | 0 |
| 2017 | - | - | -74 t. | -388 t. | 0 |
| 2016 | - | - | -45 t. | -315 t. | - |
| 2015 | - | - | -56 t. | -270 t. | - |
| 2014 | - | - | -147 t. | -214 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ACADIA PHARMACEUTICALS A/S has published its annual report for 2017. The net result was DKK -73,652.
As of May 31, 2018, Justin Thacker has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 31, 2018, Todd Young has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 31, 2018, Martin Choy has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 31, 2018, Glenn Frederick Baity has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 31, 2018, Todd Young is registered as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of May 31, 2018, Glenn Frederick Baity has stepped down as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of May 30, 2018, Justin Thacker has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 30, 2018, Todd Young has left the board of directors of ACADIA PHARMACEUTICALS A/S.
About ACADIA PHARMACEUTICALS A/S
ACADIA PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1996. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RECEPTOR TECHNOLOGIES A/S and VICH 4861 A/S. The management consists of Jennifer Jane Rhodes. The board consists of Martin Choy (chair), James Kenji Kihara, Jennifer Jane Rhodes and Peter Francis Chae. The company is owned by Acadia Pharmaceuticals Inc.. The company has 6 employees (2005). In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.